Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
J Health Popul Nutr. 2023 Jul 24;42(1):70. doi: 10.1186/s41043-023-00419-w.
Obesity is a major risk factor for chronic diseases. Politicians and practitioners should be aware of the dramatic increase in obesity and its subsequent complications to prevent associated health risks. This systematic review aimed to provide better insight into the prevalence of overweight and obesity in the Iranian population.
An evaluation was conducted on all published observational studies from both national (SID, Irandoc, Iranmedex) and international (Web of Knowledge, PubMed, Scopus) sources, which reported the prevalence of overweight/obesity among normal population samples, between January 2012 and December 2021.
A total of 152 eligible studies were included in this meta-analysis. Of the 152 selected studies, 74 reported the prevalence of overweight/obesity in patients aged ≤ 18 years, and 61 studies in adults. In the rest of the articles (17 studies), the results were reported for a combination of these age groups. The prevalence of overweight and obesity in Iran was estimated at 20.1 (95% CI 17.92-22.30) and 13.44 (95% CI 11.76-15.22), respectively. This percentage (95% CI) was 11.71 (10.98-12.46) for overweight and 8.08 (7.02-9.22) for obesity in those aged ≤ 18 years, and 35.26 (32.61-37.99) for overweight and 21.38 (19.61-23.20) for obesity in those aged > 18 years. The overall prevalence of overweight and obesity in the entire population was 35.09% (95% CI 31.31-38.98).
As obesity is on the rise in Iran, we should seek both weight loss strategies and ways to control comorbidities associated with high BMI.
肥胖是慢性病的主要危险因素。政治家和从业者应该意识到肥胖的急剧增加及其随后的并发症,以预防相关的健康风险。本系统评价旨在更深入地了解伊朗人口中超重和肥胖的流行情况。
评估了 2012 年 1 月至 2021 年 12 月期间,来自国内(SID、Irandoc、Iranmedex)和国际(Web of Knowledge、PubMed、Scopus)来源的所有已发表的观察性研究,这些研究报告了正常人群样本中超重/肥胖的流行情况。
共有 152 项符合条件的研究纳入了这项荟萃分析。在 152 项选定的研究中,有 74 项研究报告了≤18 岁患者的超重/肥胖患病率,61 项研究报告了成年人的超重/肥胖患病率。在其余的文章(17 项研究)中,结果报告了这些年龄组的综合结果。伊朗超重和肥胖的患病率估计分别为 20.1%(95%置信区间 17.92-22.30)和 13.44%(95%置信区间 11.76-15.22)。这一百分比(95%置信区间)在≤18 岁人群中分别为超重 11.71%(10.98-12.46)和肥胖 8.08%(7.02-9.22),在>18 岁人群中分别为超重 35.26%(32.61-37.99)和肥胖 21.38%(19.61-23.20)。整个人群的超重和肥胖总患病率为 35.09%(95%置信区间 31.31-38.98)。
由于肥胖在伊朗呈上升趋势,我们应该寻求减肥策略和控制与 BMI 升高相关的合并症的方法。